Alleviating Persistent Dyspnea in Amyotrophic Lateral Sclerosis Patients Treated With Non-Invasive Ventilation Through Immersive Virtual Reality

Who May Qualify: - ≥ 18 years old - Diagnosis of ALS confirmed according to the revised criteria of El Escorial - Respiratory failure due to diaphragmatic dysfunction treated by non-invasive ventilation for more than a month - Care provided in an ambulatory setting (day care hospital) - Persistent dyspnea at rest ≥ 3 across a numerical scale (0 to 10) in a semi-sitting position - Stable clinical condition, i.e., no episode of acute cardiac, respiratory and/or neurological failure leading to hospitalization in the previous 4 weeks - Free, prior and informed written consent about the study has been obtained - Benefiting a social security (French health insurance system) Who Should NOT Join This Trial: - Neurological disorders according to a neurological evaluation dating from less than one year, in particular diagnosed dementia (frontotemporal dementia, Alzheimer's disease, etc.), brain pathology (tumor, stroke, Parkinson's disease, etc.) - Diagnosed psychiatric illness (severe depression, psychosis) or receiving antipsychotic treatment - Acrophobia - Claustrophobia - Photophobia - Hearing loss - Visual impairment - Subject under guardianship or curatorship Always talk to your doctor about whether this trial is right for you.